| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-09-07 22:56:11 UTC |
|---|
| Updated at | 2022-09-07 22:56:12 UTC |
|---|
| NP-MRD ID | NP0257728 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | (5r,7as,11as)-5-butyl-decahydro-1h-pyrrolo[2,1-j]quinoline |
|---|
| Description | Lepadiformine C belongs to the class of organic compounds known as azaspirodecane derivatives. These are organic compounds containing a spirodecane moiety with at least one nitrogen atom. (5r,7as,11as)-5-butyl-decahydro-1h-pyrrolo[2,1-j]quinoline is found in Clavelina moluccensis. (5r,7as,11as)-5-butyl-decahydro-1h-pyrrolo[2,1-j]quinoline was first documented in 2010 (PMID: 21082832). Based on a literature review a small amount of articles have been published on Lepadiformine C (PMID: 32580551) (PMID: 28488778) (PMID: 28001080) (PMID: 20578697). |
|---|
| Structure | CCCC[C@@H]1CC[C@@H]2CCCC[C@]22CCCN12 InChI=1S/C16H29N/c1-2-3-8-15-10-9-14-7-4-5-11-16(14)12-6-13-17(15)16/h14-15H,2-13H2,1H3/t14-,15+,16-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| Lepadiformine b | MeSH | | Lepadiformine | MeSH | | Lepadiformine a | MeSH |
|
|---|
| Chemical Formula | C16H29N |
|---|
| Average Mass | 235.4150 Da |
|---|
| Monoisotopic Mass | 235.23000 Da |
|---|
| IUPAC Name | (7R,11aS,11bS)-7-butyl-decahydro-1H-pyrrolo[2,1-]quinoline |
|---|
| Traditional Name | (7R,11aS,11bS)-7-butyl-decahydro-1H-pyrrolo[2,1-]quinoline |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CCCC[C@@H]1CC[C@@H]2CCCC[C@]22CCCN12 |
|---|
| InChI Identifier | InChI=1S/C16H29N/c1-2-3-8-15-10-9-14-7-4-5-11-16(14)12-6-13-17(15)16/h14-15H,2-13H2,1H3/t14-,15+,16-/m0/s1 |
|---|
| InChI Key | ARTIWNYIINGTLF-XHSDSOJGSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as azaspirodecane derivatives. These are organic compounds containing a spirodecane moiety with at least one nitrogen atom. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Azaspirodecane derivatives |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Azaspirodecane derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Quinolidine
- Azaspirodecane
- Indolizidine
- N-alkylpyrrolidine
- Piperidine
- Pyrrolidine
- Tertiary aliphatic amine
- Tertiary amine
- Azacycle
- Organic nitrogen compound
- Hydrocarbon derivative
- Organonitrogen compound
- Amine
- Aliphatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aliphatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Wu JL, Chiou WH: Diastereocontrolled Formal Syntheses of (+/-)-Lepadiformines A, B, and C and the Divergent Synthesis of 2-epi-Lepadiformine C through Unexpected Double Consecutive Epimerizations. J Org Chem. 2020 Jul 17;85(14):9051-9063. doi: 10.1021/acs.joc.0c00964. Epub 2020 Jul 5. [PubMed:32580551 ]
- Nishikawa K, Yamauchi K, Kikuchi S, Ezaki S, Koyama T, Nokubo H, Matsumura K, Kodama T, Kumagai M, Morimoto Y: Total Syntheses of Lepadiformine Marine Alkaloids with Enantiodivergency, Utilizing Hg(OTf)(2) -Catalyzed Cycloisomerization Reaction and their Cytotoxic Activities. Chemistry. 2017 Jul 18;23(40):9535-9545. doi: 10.1002/chem.201701475. Epub 2017 Jun 9. [PubMed:28488778 ]
- Lee S, Bae M, In J, Kim JH, Kim S: Asymmetric Total Synthesis of Lepadiformine C Using Memory of Chirality in an Intramolecular Ester Enolate Michael Addition. Org Lett. 2017 Jan 6;19(1):254-257. doi: 10.1021/acs.orglett.6b03550. Epub 2016 Dec 21. [PubMed:28001080 ]
- Weidner K, Giroult A, Panchaud P, Renaud P: Efficient carboazidation of alkenes using a radical desulfonylative azide transfer process. J Am Chem Soc. 2010 Dec 15;132(49):17511-5. doi: 10.1021/ja1068036. Epub 2010 Nov 17. [PubMed:21082832 ]
- Perry MA, Morin MD, Slafer BW, Wolckenhauer SA, Rychnovsky SD: Fully substituted carbon centers by diastereoselective spirocyclization: stereoselective synthesis of (+)-lepadiformine C. J Am Chem Soc. 2010 Jul 21;132(28):9591-3. doi: 10.1021/ja104250b. [PubMed:20578697 ]
- LOTUS database [Link]
|
|---|